Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein

被引:66
作者
Hofmeister, R
Wiegmann, K
Korherr, C
Bernardo, K
Kronke, M
Falk, W
机构
[1] UNIV REGENSBURG,DEPT INTERNAL MED 1,D-93042 REGENSBURG,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,INST IMMUNOL,D-24105 KIEL,GERMANY
关键词
D O I
10.1074/jbc.272.44.27730
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine interleukin-1 (IL-1) plays an important role in inflammation and regulation of immune responses, but the mechanisms of its signal transduction and cell activation processes are incompletely understood. Ceramide generated by sphingomyelinases (SMases) is known to function as an important second messenger molecule in the signaling pathway of IL-1 and tumor necrosis factor. To investigate the activation of SMases by IL-1, we used an IL-1 receptor type I (IL-1RI)-positive EL4 thymoma cell line, which is defective in IL-1R accessory protein (IL-1RAcP) expression. In this cell line (EL4D6/76), tumor necrosis factor induced ligand/receptor internalization, NF kappa B nuclear translocation, IL-2 production, and the activation of neutral (N)-SMase and acid (A)-SMase. In contrast, stimulation with IL-1 resulted only in the activation of N-SMase whereas ligand/receptor internalization, NF kappa B translocation, IL-2 production, and activation of A-SMase were not detected. Transfection of this functionally defective EL4D6/76 with IL-1RAcP cDNA restored these functions. These data suggest that A-SMase activity is strongly linked with the internalization of IL-1RI mediated by IL-1RAcP and that A-SMase and N-SMase are activated by different pathways.
引用
收藏
页码:27730 / 27736
页数:7
相关论文
共 52 条
[1]   A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway [J].
Adam, D ;
Wiegmann, K ;
AdamKlages, S ;
Ruff, A ;
Kronke, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14617-14622
[2]   LOW-TEMPERATURES AND HYPERTONICITY DO NOT BLOCK CYTOKINE-INDUCED STIMULATION OF THE SPHINGOMYELIN PATHWAY BUT INHIBIT NUCLEAR FACTOR-KAPPA-B ACTIVATION [J].
ANDRIEU, N ;
SALVAYRE, R ;
JAFFREZOU, JP ;
LEVADE, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24518-24524
[3]  
BALLOU LR, 1992, J BIOL CHEM, V267, P20044
[4]   TUMOR-NECROSIS-FACTOR (TNF)-ALPHA ACTIVATES C-RAF-1 KINASE VIA THE P55 TNF RECEPTOR ENGAGING NEUTRAL SPHINGOMYELINASE [J].
BELKA, C ;
WIEGMANN, K ;
ADAM, D ;
HOLLAND, R ;
NEULOH, M ;
HERRMANN, F ;
KRONKE, M ;
BRACH, MA .
EMBO JOURNAL, 1995, 14 (06) :1156-1165
[5]   MOLECULAR MECHANISMS OF TUMOR NECROSIS FACTOR-INDUCED CYTOTOXICITY - WHAT WE DO UNDERSTAND AND WHAT WE DO NOT [J].
BEYAERT, R ;
FIERS, W .
FEBS LETTERS, 1994, 340 (1-2) :9-16
[6]   CD28 SIGNALS THROUGH ACIDIC SPHINGOMYELINASE [J].
BOUCHER, LM ;
WIEGMANN, K ;
FUTTERER, A ;
PFEFFER, K ;
MACHLEIDT, T ;
SCHUTZE, S ;
MAK, TW ;
KRONKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2059-2068
[7]  
BRADLEY JR, 1993, J IMMUNOL, V150, P5544
[8]  
BROOKS JW, 1994, EUR CYTOKINE NETW, V5, P547
[9]   THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1 [J].
COLOTTA, F ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
IMMUNOLOGY TODAY, 1994, 15 (12) :562-566
[10]   NF-KAPPA-B ACTIVATION BY INTERLEUKIN-1 (IL-1) REQUIRES AN IL-1 RECEPTOR-ASSOCIATED PROTEIN-KINASE ACTIVITY [J].
CROSTON, GE ;
CAO, ZD ;
GOEDDEL, DV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16514-16517